1/95
Looks like no tags are added yet.
bacteriostatic agents
inhibit bacterial growth, gets rid of bacterial infection through immune system
bacteriocidal agents
kill bacteria
things to consider when rationally selecting antibacterial agents
- identification of organism (gram - or +)
- script based on history and status of patient, compliance
- MOA of antibiotic
- site of infection
- safety cost
- routes of admin
bacteriostatic antibiotics at high concentration
can become bacteriocidal
Minimum inhibitory concentration (MIC)
the smallest concentration (highest dilution) of drug that visibly inhibits growth
MBC
minimal bactericidal concentration
antibiotics that are not safe during pregnancy
tetracyclines, trimethoprim-sulfamethoxazole, chloramphenicol
rational dosing takes into account
- concentration-dependent killing
- time-dependent killing
- postantibiotic effects
narrow spectrum antibiotics
- Effective against specific bacteria
- mostly TB drugs
extended spectrum antibiotics
- some gram + (cocci and bacili)
- some gram - (rods)
broad spectrum antibiotics
- affect a broad range of gram-positive or gram-negative bacteria
- can cause superinfections
superinfection
- kill off normal flora, causing overgrowth of bacteria regulated by normal flora
- clostridium difficile
combination antibiotics
- can be synergistic
- most times there’s interference between them
- don’t want to combine antibiotics with same MOA
drug resistance occurs through
genetic alteration, altered expression of proteins, prophylactic use
complications of antibiotic therapy
hypersensitivity (hapten effect), direct toxicity, superinfections
sites of antibacterial action
inhibitors of metabolism, cell wall function/synthesis, protein synthesis, nucleic acid function/synthesis,
bacterial cell wall
- composed of peptidoglycans
- drugs act on proliferating cells only
classes of cell wall inhibitors
penicillins
cephalosponins
carbapenems
monobactams
penicillins MOA
- B-lactam
- binds to enzymes responsible for cell wall synthesis (PEP), inhibit transpeptidase, produce autolysins
- insert B-lactam ring into cell wall
- bacteriocidal
penicillins spectrum
- extended, great for gram +
- MRSA, syphilis, anthrax, gonorrhea, pneumococcal pneumonia
penicillins not good for
mycoplasma pneumonia
penicillin resistance
B-lactamase, efflux pumps, altered PBPs
penicillin resistance rescue
addition of clavulanic acid inactivates B-lactamase, penicillin can do its job
clavulanic acid resistance
nothing is resistant to clavulanic acid
kinetics of penicillins
- oral admin is variable, inhibited by food
- doesn’t penetrate bone, CSF, or prostate
- no metabolic disruptions
- renal excretion
adverse effects of penicillins
hypersensitivity, diarrhea, nephritis, neurotoxicity, hematologic
hapten effect of penicillins
anemia
cephalosporins MOA
- B-lactams
- similar mechanism and use as penicillans
- more resistant to some B-lactamases
cephalosporin generations
- 2nd gens have greater gram - activity
- 3rd gens begin to cross BBB (good for meningitis)
- 4th gens are parenteral admin
- advanced are IV admin, MRSA
cephalosporin kinetics
IM/IV admin, some BBB penetration, elimination via tubular secretion
adverse effects of cephalosporins
similar to penicillins
carbapenems
synthetic
imipenem: resistant to B-lactamase but not metallo-B-lactamase
CSF penetration, eliminated via kidneys
monobactams
spectrum against gram -
vancomycin
useful against MRSA, oral administration for C. diff
daptomycin
useful against MRSA, disrupts cell membrane
not useful for pneumonia
telavancin
synthetic derivative of vancomycin, disrupts cell membrane
fosfomycin
derivative of phosphonic acid, stops cell wall synthesis at first step
B-lactamase inhibitors
**clavulanic acid
- sublactam
- tazobactam
- used as adjunct therapy
uses of polymyxins
polymyxin B - opthalmic ointment, salvage drug
polymyxins MOA
bind to phospholipids on cell membrane
protein synthesis inhibitors
inhibit bacterial ribosomes, bacteriostatic
tetracyclines MOA
reversibly bind to 30s subunit, bacteriostatic
tetracyclines spectrum
broadest
tetracycline resistance
via bacterial efflux pumps
where do tetracyclines bind
calcium rich tissues (bone, teeth), pose a issue for use in development, slows OB activity
tetracyclines kinetics
impaired by Ca2+/Mg2+ (don’t take with milk)
adverse effects of tetracyclines
- GI pain, deposition in calcified tissue, hepatotoxicity, phototoxicity, pseudotumor cerebri
pseudotumor cerebri
intracranial and CSF pressure builds
tetracycline use is not reccommended for
pregnant, young
diseases treated by protein synthesis inhibitors like tetracyclines
lyme disease, cholera, chlamydia, mycoplasma pneumonia, rocky mountain spotted fever
length of treatment using bateriocidal/bacteriostatic antibiotics
bacteriostatic drug use is often longer than bactericidal
glycyclcyclines (tigecycline) MOA
reversibly bind to 30s subunit
glycyclcyclines spectrum
- broad spectrum
- good on intra-abdominal infections
glycyclcyclines resistance
efflux pumps
glycyclcyclines adverse effects
acute pancreatitis
aminoglycosides MOA
- bind to 30s subunit
- bacteriocidal at 8-10x MIC
- prolonged postantibiotic effect, extended dosing intervals
aminoglycosides resistance
efflux pumps, decreased uptake, inactivation
diseases treated by aminoglycosides
tularemia (from rabbits)
aminglycosides synergism
can be added to B-lactams (penicillins) for synergy for select gram positive infections
aminglycosides dosing
- high water solubility
- dose based on lean body mass, not weight
- low TI
adverse effects of aminglycosides
ototoxicity, nephrotoxicity, paralysis (temporary), contact dermatitis
(erythromycin) macro- & ketolides MOA
- irreversibly bind to 50S subunit
- bacteriocidal
- preferred treatment for chlamydia
macro- & ketolides spectrum
- broad spectrum
- originally replacement for penicilin allergy
macro- & ketolides kinetics
doesn’t cross BBB, concentrates in immune cells (macrophages), high apparent Vd
macro- & ketolides adverse effects
GI distress, cholestatic jaundice, oxotoxicity
macro- & ketolides contraindications
hepatic impairment, drug interactions
Fidaxomicin MOA
inhibits sigma subunit of RNA polymerase
use of Fidaxomicin
C. diff, low oral absorption
Fidaxomicin spectrum
gram + aerobes & anaerobes
Chloramphenicol MOA
- binds to 50s
- affects mammalian mitochondira
- bone marrow suppression with oral form
Chloramphenicol spectrum
microorganisms, not just bacteria
adverse effects of Chloramphenicol
anemia, gray baby syndrome (affects fetal mitochondria, cyanosis)
Chloramphenicol resistance
enzymatic inactivation
clindamycin MOA
same as erythromycin, MRSA, anaerobic
Quinupristin / Dalfopristin
target 50S subunit, gram + cocci
linezolid
binds to 23S rRNA, gram +, TB
linezolid adverse effects
thrombocytopenia, serotonin syndrome (MAOI)
Quinolones mediate their effect by
inhibiting DNA gyrase
Fluoroquinolones (Quinolones) MOA
fully synthetic, inhibit DNA gyrase/topoisomerase IV, bacteriocidal
Fluoroquinolones generations
- 1st gen: nalidixic acid
- 2nd gen: cipro
- 3rd gen: Levo, most used now, good bioavailability
- 4th gen: moxifloxacin, used in hospitals
cipro is not drug of choice for
pneumonia or sinusitis, bc it has weak activity against S. pneumoniae
use of Fluoroquinolones
anthrax, UTI, respiratory/GI infections
Fluoroquinolones resistance
chromosomal mutation, altered target, decreased accumulation
adverse effects of Fluoroquinolones
tendon rupture, impairs growth
folate antagonists
- folic acid is a precursor for RNA and DNA
- impair bacterial synthesis
- bacteriocidal
sulfonamides (folate antagonists) MOA
- interfere with formation of dihydrofolic acid from PABA
- can reproduce effects of folic acid deficiency
sulfonamides resistance
- not a lot of resistance, resistance due to altered dihydrofolate reductase
use of folate antagonists
MRSA, prostate/UTI, listeriosis, respiratory/GI
sulfonamides kinetics
rapid oral absorption
interfering with folic acid can
- stop/kill bacteria
- kill tumor cells
- stop virus replication
Cotrimoxazole (sulfamethoxazole and trimethoprim)
- folate antagonist, inhibition of dihydrofolic acid synthesis
- greater inhibition of bacterial growth
- good penetration to brain and prostate
- resistance not common
Cotrimoxazole adverse effects
rash, hematologic toxicity
methenamine (urinary tract antiseptic) MOA
- decomposes in pH 5.5 to formaldehyde (not effective in alkaline pH)
- spectrum - most all except urea splitters
- prevents bacteria from adhering to urinary walls
- associated w cranberry juice
acidity of urine for use of antiseptics
- carnivores have relatively acidic urine
- if patient is vegetarian/herbivore they need to be put on a urine acidifier before using antiseptic
is bladder sterile
- no, low level microbial population present
- not robust, changes in envronment can prevent bacteria
antibiotic vs antiseptic
- antibiotic focuses on bacteria
- antiseptic prevent sepsis/infection (nonspecific)